Company intelligence / Profile preview

Solvotrin Therapeutics

Cork, Cork, Irelandactiveiron.com ↗
Ownership
Private
Employees
~21
Development stage
Commercial
01

Overview

Active Iron is clinically proven to be significantly better absorbed than the gold standard ferrous sulfate while avoiding negative gastrointestinal side effects commonly associated with oral iron[4][7].

Therapeutic areas
OncologyDermatologyImmunologyHematology
Modalities
Small moleculesoral iron supplements
Industry
Biotech
02

Drug pipeline

4 assets

Active Iron

Preclinical

3 more assets in the full pipeline.

03

Partnerships

Norwell Consumer Healthcare (Canada)Shanghai Fosun Pharmaceutical (China)

Beyond the preview

Go deeper on Solvotrin Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solvotrin Therapeutics.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call